TE_38
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MLT1B |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 1.36 |
| Counts of samples | TCGA_tumor:64; TCGA_normal:2; GTEx:51 |
| TSS | chr1(-):2575428 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):2571013,2571033,2574770,2575096,2575308,2575429 |
| teRNA_38.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):2570712,2570732,2570925,2571033,2575308,2575429 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
